Neurizon Issues Over 63 Million Shares, Including Placement Shares and Vested Rights
NUZ: $0.060 -6.25% · MC: $48M
Neurizon Therapeutics issued over 63 million ordinary shares, including shares from its previously announced placement, vested performance rights and part-payment for investor relations services. The placement accounts for most of the issue; the performance-right conversion also reduced the remaining rights on issue.

Comments